WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

Vertex Pharmaceuticals (VRTX) closed at $502.55 in the latest trading session, marking a +0.45% move from the prior day.

In this article, we are going to look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market ...

Vertex Pharmaceuticals (NasdaqGS ... This progress, along with the recent approval of ALYFTREK in the UK for cystic fibrosis, might have... We recently published a list of 20 Most Expensive ...

The developer of a spray-based erectile dysfunctional treatment, LTR Pharma has found a pre-approval route to the ... market ...

Tokyo, Japan and Cambridge, UK, 25 March 2025 - Nxera Pharma Co., Ltd. ("Nxera" or "the Company"; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a pot ...

Investing.com -- According to Reuters, several drugmakers have reportedly begun accelerating shipments of medicines to the ...

The UK could be “less interesting” to pharma and life sciences firms after ... Roche is increasing its stock of medicines, in line with its peers, in the event of a no-deal Brexit, Schwan ...

Hikma Pharmaceuticals is a global drug ... Spire Healthcare is the UK’s largest independent hospital stock serving the private healthcare sector. The company has 72 facilities scattered across ...

Indian benchmark indices recovered on Thursday after a weak opening, with the Sensex gaining 210 points and the Nifty 50 ...

Harami Cross 15 69 Mar 26, 2025 00:30 ...

The benchmark BSE Sensex slipped 0.25% to close at 77,414, while the broader NSE Nifty 50 fell 0.41% to 23,494, weighed down ...